Cite
MLA Citation
David A Margolis et al.. “Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial.” Lancet infectious diseases, vol. 15, no. 10, n.d., pp. 1145–1155. http://access.bl.uk/ark:/81055/vdc_100051211756.0x000027